Here, we report that UNC93B1 regulates a step upstream of the differential TLR trafficking process. We discovered that UNC93B1 deficiency resulted in near-complete loss of TLR3 and TLR7 proteins in primary splenic mouse dendritic cells and macrophages, showing that UNC93B1 is critical for maintaining TLR expression. Notably, expression of an ER-retained UNC93B1 version was sufficient to stabilize TLRs and largely restore endosomal TLR trafficking and activity. These data are critical for an understanding of how UNC93B1 can regulate the function of a broad subset of TLRs.
INTRODUCTION
One of the strategies by which the innate immune system can detect invading microbes is by recognizing their nucleic acids (NAs). It has been proposed that the compartmentalization of NA-sensing TLR activity to endosomes and phagosomes ensures efficient sensing of microbial NAs and limits autoimmunity against host NAs. In fact, endosomal acidification and endosomal TLR processing are required for effective NA-sensing TLR activation (Blasius and Beutler, 2010) .
The polytopic membrane protein UNC93B1 is a cofactor required for NA-sensing TLRs (Tabeta et al., 2006) . According to the current model, UNC93B1 exerts its critical function by enabling trafficking of NA-sensing TLRs from the endoplasmic reticulum (ER) to endosomal compartments (Kim et al., 2008) and thereby facilitates TLR cleavage and ligand recognition. This notion is mostly based on experiments using an Unc93b1 loss-of-function mutant that was identified with a forward genetic screen and termed ''triple defect (3d) mutant'' (Kim et al., 2008; Tabeta et al., 2006) . This mutant carries a single point mutation changing histidine 412, located in one of the predicted transmembrane domains of UNC93B1, to arginine (H412R). In the presence of UNC93B1 H412R, all UNC93B1-dependent TLR activity is abolished and neither UNC93B1 itself nor the UNC93B1-dependent TLRs are able to reach ligandcontaining endosomal compartments (Kim et al., 2008) . Various studies in mouse also suggest a regulatory function of UNC93B1 in the fine-tuning of NA-sensing TLR responses (Fukui et al., 2009; Lee et al., 2013) and show that dysregulation at the level of UNC93B1 leads to autoinflammatory diseases (Fukui et al., 2011) . The fact that human patients lacking functional UNC93B1 develop Herpes simplex virus type 1 (HSV-1) encephalitis emphasizes the importance of UNC93B1 in NA recognition and host defense (Casrouge et al., 2006) .
Recently, it has been recognized that the requirement for UNC93B1 is not restricted to NA-sensing endosomal TLRs. Instead, UNC93B1 is also required for the cell-surface expression of the flagellin-sensing TLR5 (Huh et al., 2014) , whereas other cell-surface TLRs, such as TLRs 2 or 4, function independently of UNC93B1 (Huh et al., 2014; Kim et al., 2008; Tabeta et al., 2006) . Considerable advancement in the development of TLR-specific antibodies provides growing evidence that mouse TLRs 3 (Murakami et al., 2014) , 7 (Kanno et al., 2015) , and 9 , classically defined as endosomal TLRs, also localize to the cell surface of primary splenic DCs, B cells, and macrophages. Cell-surface TLRs 3 and 7 are proteolytically cleaved and therefore are not immature full-length receptors that pass the cell surface on their way to endosomes (Kanno et al., 2015; Murakami et al., 2014) . Whether these TLRs can be activated from the cell surface is still an open question.
The role of UNC93B1 for TLRs that are not, or not only, localized to endosomal compartments raises the question of whether UNC93B1 has additional functions independent of its endosomal trafficking activity. Notably, UNC93B1 H412R not only is impaired in its ability to traffic to endosomes (Kim et al., 2008) but also is unable to interact with TLRs within the ER (Brinkmann et al., 2007) . Consequently, trafficking-independent functions of UNC93B1 would be missed in studies relying on this non-functional version of UNC93B1.
Here, we designed an ER-retained version of UNC93B1 that, unlike the UNC93B1 H412R mutant, still interacts with TLRs. Notably, this ER-retained version of UNC93B1 was sufficient to enable TLR trafficking and restore proinflammatory cytokine responses. Furthermore, in the absence of UNC93B1 or the presence of UNC93B1 H412R, endogenous UNC93B1-dependent TLRs were not only trafficking defective but also absent on the protein level. Both wild-type (WT) UNC93B1 and ER-retained UNC93B1 rescued TLR protein expression and function. These data indicate that UNC93B1 serves a critical function independent of its endosomal trafficking activity, namely to stabilize TLR proteins and prevent their degradation.
RESULTS

UNC93B1 WT-ER Is a Trafficking-Defective Version of UNC93B1
According to the current model, UNC93B1 acts as a trafficking chaperone that is crucial for guiding TLRs to endosomal compartments (Kim et al., 2008; Lee et al., 2013) . To discover possible trafficking-independent functions of UNC93B1, we generated a trafficking-defective version of UNC93B1 (UNC93B1 WT-ER) by adding previously described ER retention signals (Schutze et al., 1994) to both N-and C-termini of UNC93B1 ( Figure 1A ). These ER retention signals recruit the COPI-dependent retrograde trafficking machinery (LippincottSchwartz et al., 2000) and thus prevent membrane proteins from entering the secretory pathway. Unlike the traffickingdefective UNC93B1 H412R mutant, whose internal point mutation abrogates its interaction with TLRs, the WT-ER version of UNC93B1 should be impaired in its endosomal trafficking ability but capable of binding TLRs within the ER. Confocal microscopy of HEK293 cells ( Figure 1B ) and Unc93b1 À/À immortalized macrophages (iMOs) ( Figure 1C ) reconstituted with the different human and mouse versions of UNC93B1-mCitrine, respectively, suggested the presence of WT UNC93B1 in endosomes, whereas the expression of both UNC93B1 H412R and UNC93B1 WT-ER were restricted to the ER. Cryo-electron microscopy (cryo-EM) of macrophages expressing UNC93B1 WT, H412R, or WT-ER confirmed that only WT UNC93B1, but not UNC93B1 H412R or WT-ER, was detectable in Golgi and endosomal compartments, but all three versions of UNC93B1 were present in the ER ( Figure S1 ). To further analyze the trafficking defect of UNC93B1 WT-ER, we assessed the glycosylation pattern of the different UNC93B1 versions expressed in Unc93b1 À/À macrophages. Proteins that traffic through the Golgi apparatus acquire complex oligosaccharide structures. These can be experimentally removed by the enzyme peptide-N-glycosidase F (PNGase F) but are resistant to cleavage by the enzyme endoglycosidase H (Endo H). A small portion of WT UNC93B1 that was immunoprecipitated from macrophages carried Endo H-resistant oligosaccharides, which is indicative of its trafficking through the Golgi apparatus ( Figure 1D , star indicates Endo H-resistant fraction). In contrast, neither UNC93B1 H412R nor UNC93B1 WT-ER gained Endo H resistance, confirming that these UNC93B1 versions are retained in the ER. Next, we immunoprecipitated the different versions of UNC93B1 from Unc93b1 À/À macrophages that were lysed with digitonin so that the intracellular membranes would remain partly intact (Meunier and Broz, 2015) , and performed quantitative proteomics in order to gain insights into the subcellular compartments that are populated by UNC93B1 WT, H412R, and WT-ER. Although we detected comparable amounts of endogenous TLRs 3, 7, 8, 9, and 13 in UNC93B1 WT and WT-ER immunoprecipitates, these TLRs were significantly less abundant in UNC93B1 H412R immunoprecipitates ( Figure  2A , shown are the log2-fold changes of UNC93B1 H412R and WT-ER compared to UNC93B1 WT). UNC93B1 H412R immunoprecipitates also contained fewer ER chaperones that had been previously identified as TLR cofactors; namely, such chaparones included gp96 (Hsp90b1) (Yang et al., 2007) and PRAT4A (Cnpy3) (Takahashi et al., 2007) (Figure 2A ). The same was true for the beta subunit of glucosidase II, also known as protein kinase C substrate 80K-H, and peptidyl-prolyl cistrans isomerase B. Both of these ER-resident proteins are involved in the maturation of proteins and, to our knowledge,
have not yet been investigated with regard to their role for TLR function. Notably, the proteins Ube2g2 and Aup1, which are both implicated in the ER degradation pathway (Jo et al., 2013) , and proteasomal subunits such as Psmb8 and Psmb9 were significantly enriched in UNC93B1 H412R immunoprecipitates ( Figure 2A ). In contrast to immunoprecipitates of UNC93B1 H412R, UNC93B1 WT-ER showed no significant decrease in ER chaperones and no enrichment for proteasomal components when compared to UNC93B1 WT. In accordance with the design of UNC93B1 WT-ER, we detected an enrichment of COPI coat molecules (such as Copa, Cope, and Copb1) and the GTPase-activating protein Arfgap1 in UNC93B1 WT-ER immunoprecipitates (Figure 2A ), indicating that UNC93B1 WT-ER is most likely still exported from the ER but then retrieved from the cis-Golgi and transported back to the ER via COPI-coated vesicles. Importantly, several proteins involved in post-Golgi trafficking pathways were significantly depleted in both UNC93B1 H412R and UNC93B1 WT-ER immunoprecipitates when compared to WT UNC93B1 ( Figure  2A) ; among them were proteins involved in the Golgi-to-endosome trafficking process (such proteins include Syntaxin 4, Vamp4, Scamp2, Scamp3, and Golga7), regulators of endosome-to-lysosome trafficking (examples include Vamp7, Lamp2, and Scarb2), and trafficking molecules (namely AP2 and Syntaxin 7) involved in the endocytosis pathway from the cell membrane to endosomes. The complete proteomics dataset is available in Table S1 . The lysosomal membrane protein Scarb2 (also known as Limp-2) and the adaptor protein 2 (AP2), which mediates clathrin-dependent endocytosis of proteins, have been previously identified in TLR and UNC93B1 trafficking pathways (Guo et al., 2015; Lee et al., 2013; Pelka et al., 2014) . Furthermore, TLRs were reported to reside in and signal from Lamp2-positive compartments (Sasai et al., 2010) . Hence, our proteomics approach captures known trafficking pathways of UNC93B1 and TLRs and indicates that only UNC93B1 WT, but not UNC93B1 H412R or WT-ER, is able to transit the Golgi apparatus and reach endolysosomal compartments. The depletion of both UNC93B1 H412R and UNC93B1 WT-ER from Golgi apparatus, the trans-Golgi network, early endosomes, late endosomes, lysosomes, and the plasma membrane was also confirmed by Gene Ontology enrichment analyses. (B) HEK293 cell lines stably expressing human UNC93B1-mCitrine WT, H412R, or WT-ER were transiently transfected with a plasmid encoding the ER marker mCherry-KDEL and analyzed by confocal microscopy. Endosomal structures in representative images are indicated by arrows, and the number of endosomal structures per cell was quantified. Data are combined from three independent experiments with 20 cells per experiment; each dot represents one cell. Significance was determined by Kruskal-Wallis statistics (p < 0.0001) followed by pairwise comparisons between groups (**** indicates p < 0.0001, as determined by Mann-Whitney U-test statistics). Scale bars, 5 mm.
(C) Unc93b1 À/À iMOs stably expressing UNC93B1-mCitrine WT, H412R, or WT-ER were analyzed by confocal microscopy. Endosomal structures in representative images are indicated by arrows, and the number of vesicular structures per cell was quantified. Data are combined from three independent experiments with 50 cells per experiment; each dot represents one cell. Significance was determined by Kruskal-Wallis statistics (p < 0.0001) followed by pairwise comparisons between groups (**** indicates p < 0.0001, as determined by Mann-Whitney U-test statistics). Scale bars, 5 mm.
(D) UNC93B1-mCitrine WT, H412R, or WT-ER were immunoprecipitated from Unc93b1 À/À iMOs stably expressing the different versions of UNC93B1. IPs were denatured and either left untreated or deglycosylated with the enzymes endoglycosidase H (H) or peptide-N-glycosidase F (F), as indicated. Samples were separated on a 4%-12% gradient gel, and UNC93B1-mCitrine versions were detected by immunoblotting with anti-GFP antibody. Endo H-resistsant forms are indicated with a star. Data are representative of three independent experiments. Please also see Figure S1 for cryo-EM pictures of Unc93b1 À/À iMOs stably expressing UNC93B1-mCitrine WT, H412R, or WT-ER.
annotations were identified when UNC93B1 WT-ER was compared to UNC93B1 H412R, suggesting that both of these UNC93B1 versions are indeed equally impaired in their transGolgi and endosomal trafficking ability. To further characterize the trafficking abilities of the different ER-resident UNC93B1 versions, we assessed whether they can still be recruited to endosomal TLR ligands upon stimulation. To this end, we incubated Unc93b1 À/À iMOs expressing UNC93B1 WT, H412R, or WT-ER with fluorescent TLR9-stimulatory DNA ( Figure 2C ) and TLR7-stimulatory RNA-streptavidin complexes ( Figure 2D ) and quantified the recruitment of UNC93B1 to TLR-ligand-containing endosomes. Unlike WT UNC93B1, both UNC93B1 H412R and UNC93B1 WT-ER were excluded from TLR-ligand-containing endosomes. Together, these data indicate that UNC93B1 WT-ER is defective in its constitutive and stimulation-induced post-Golgi trafficking abilities but does not suffer from the disruptive effects of the H412R point mutation in the UNC93B1 3d mutant.
ER-Retained UNC93B1 Is Sufficient to Restore TLR-Induced Proinflammatory Cytokine Secretion We next addressed how the expression of UNC93B1 WT-ER impacts TLR responses. We analyzed proinflammatory cytokine secretion upon stimulation with UNC93B1-dependent TLR ligands (TLR7-stimulatory RNA and R848, TLR9-stimulatory CpG1826, and TLR13-stimulatory RNA derived from S. aureus ribosomal RNA) and UNC93B1-independent TLR ligands (TLR4-stimulating LPS) (Kim et al., 2008; Tabeta et al., 2006) . As expected, UNC93B1 WT, but not UNC93B1 H412R, was able to restore the activities of UNC93B1-dependent TLRs 7, 9, and 13 in Unc93b1 À/À iMOs ( Figure 3A) .
Notably, UNC93B1-dependent TLR responses were largely intact in iMOs expressing UNC93B1 WT-ER. TLR4 was equally active independent of the absence or presence of UNC93B1, confirming that TLR signaling pathways and cytokine secretion in general were unimpaired in the absence of UNC93B1. To address whether overexpression of the UNC93B1 versions Table S1 for the complete dataset. (B) 1D enrichment analysis of selected Gene Ontology terms, namely Golgi apparatus (Golgi), trans-Golgi network (TGN), early endosome (EE), late endosome (LE), lysosome (LY), and the plasma membrane (PM), for the indicated pairwise comparisons (Benjamini-Hochberg corrected FDR cutoff of 5%).
(C) Unc93b1 À/À iMOs expressing the indicated versions of UNC93B1 were fed with fluorescent CpG1826 and analyzed by confocal microscopy. The graph shows the mean object-based colocalization of UNC93B1 with DNA vesicles relative to UNC93B1 WT. Each data point represents the mean of one independent experiment with thousands of DNA vesicles each. Shown are data from three independent experiments (mean ± SEM). A Shapiro-Wilk normality test showed normal distribution of data, and an Anova revealed significance (p = 0.0017). * indicates p < 0.05 for pairwise comparisons among groups (via paired t test statistics). Scale bars, 10 mm. (D) Unc93b1 À/À iMOs expressing the indicated versions of UNC93B1 were fed with fluorescent biotinylated RNA-streptavidin complexes and analyzed by confocal microscopy. The graph shows the mean object-based colocalization of UNC93B1 with RNA vesicles relative to UNC93B1 WT. Each data point represents the mean of one independent experiment with thousands of RNA vesicles each. Shown are data from three independent experiments (mean ± SEM). A Shapiro-Wilk normality test showed normal distribution of data, and an Anova revealed significance (p = 0.0004). * indicates p < 0.05 for pairwise comparisons among groups via paired t test statistics). Scale bars, 10 mm.
affected our results, we used intracellular flow cytometry to compare the protein expression of UNC93B1-mCitrine WT, H412R, and WT-ER in Unc93b1 À/À macrophages with that of endogenous UNC93B1 in WT macrophages. We measured a moderate four-fold higher expression of UNC93B1-mCitrine compared to endogenous UNC93B1 (data not shown). Thus, we repeated our stimulation experiments in cell lines adjusted to endogenous UNC93B1 protein concentrations and confirmed that physiologic amounts of both UNC93B1 WT and UNC93B1 WT-ER were able to restore the activities of UNC93B1-dependent TLRs 7, 9, and 13 in Unc93b1 À/À macrophages ( Figure S2 ).
In previous studies, we found that mutation of UNC93B1 can result in cell-type-specific effects . We therefore extended our study to primary M-CSF-derived bone marrow macrophages (BMDMs) ( Figure 3B ) and GM-CSF-derived bone marrow dendritic cells (BMDCs) ( Figure 3C ). Similar to our results in iMOs, reconstitution of primary Unc93b1 À/À BMDMs and BMDCs with UNC93B1 WT-ER, but not UNC93B1 H412R, restored UNC93B1-dependent TLR responsiveness. In addition to the synthetic ligands, we also included heat-inactivated group B streptococcus (GBS) in our analysis. GBS is a gram-positive bacterium whose RNA has been previously shown to trigger TLR7-and TLR13-dependent immune responses (Mancuso (A) Unc93b1 À/À iMOs reconstituted with the indicated versions of UNC93B1-mCitrine were stimulated for 14 hr with increasing concentrations of ligands for TLRs 7 (TLR7-stimulatory RNA and R848), 9 (CpG1826), 13 (TLR13-stimulatory RNA), and 4 (LPS) and analyzed for IL-6 secretion. Shown are combined data from three independent experiments (mean + SEM).
(B) Primary Unc93b1 À/À BMDMs reconstituted with the indicated versions of UNC93B1-mCitrine were stimulated for 14 hr with ligands for TLRs 4 (1 ng/mL LPS), 7 (2 mM TLR7 RNA and 15 ng/mL R848), 9 (100 nM CpG1826), 13 (1 mg/mL TLR13 RNA), and heat-killed group B streptococcus (500 ng/mL GBS), and supernatants were analyzed for secreted IL-6 by ELISA. Data are representative of two independent experiments performed in triplicates (mean + SD).
(C) Primary Unc93b1 À/À BMDCs reconstituted with the indicated versions of UNC93B1-mCitrine were stimulated for 14 hr with ligands for TLRs 4 (0.5 ng/mL LPS), 7 (1 mM TLR7 RNA and 15 ng/mL R848), 9 (100 nM CpG1826), 13 (1 mg/mL TLR13 RNA), and heat-killed group B streptococcus (125 ng/mL GBS) and analyzed for IL-6 secretion. Data are representative of two independent experiments performed in triplicates (mean + SD).
(D) UNC93B1 À/À THP-1 monocytes generated by CRISPR/Cas9-mediated genome editing and retrovirally transduced with human UNC93B1-mCitrine WT or WT-ER were differentiated with 10 nM PMA overnight, washed, stimulated for 14 hr with 2.5 mg/mL R848, 5 mM TLR7 stimulatory RNA, or 2.5 ng/mL IL-1b, and analyzed for TNF secretion. Data are combined from three independent experiments (mean + SEM).
(E) EBV-immortalized B cells from an UNC93B1-deficient patient were retrovirally transduced with human UNC93B1-mCitrine WT or WT-ER and stimulated for 14 hr with 2 mg/mL R848, 5 mM TLR7 stimulatory RNA, or 2 mM CpG2006 and analyzed for IL-6 secretion. Data are combined from three independent experiments (mean + SEM).
Please also see Figure S2 . Signorino et al., 2014) . To validate our findings in human cells, we made use of previously described UNC93B1
THP-1 cells Schmid-Burgk et al., 2014) (Figure 3D) and EBV-immortalized B cells ( Figure 3E ) derived from an UNC93B1-deficient patient with herpes simplex encephalitis (Casrouge et al., 2006) and reconstituted these cells with the respective human WT and ER-retained versions of UNC93B1. Again, the ER-retained version of UNC93B1 was sufficient to largely restore immune responses. Although the exclusion of both UNC93B1 H412R and WT-ER from endosomal compartments was validated by multiple different approaches, including confocal microscopy, cryo-EM, glycosylation assays, and proteomics, it remains possible that these ER-retained versions of UNC93B1 leak into endosomal compartments in amounts that are below the detection limit of the applied assays. Unlike UNC93B1 H412R, UNC93B1 WT-ER retains its ability to interact with TLRs. Thus, minute amounts of UNC93B1 WT-ER in endosomal compartments could potentially be functionally important. To explore the possibility that small amounts of UNC93B1 could be sufficient to fully restore TLR responses, we switched to HEK293 cells, in which it is possible to tightly titrate UNC93B1 expression and analyze corresponding TLR activities. Similar to our results in mouse and human immune cells, both UNC93B1 WT and UNC93B1 WT-ER were able to confer the function of TLRs 7 and 9 in HEK293 cells stably expressing the respective TLRs ( Figure 4A ). Tumor necrosis factor receptor signaling was intact independently of UNC93B1. Next, we titrated the expression of both UNC93B1-mCitrine versions ( Figure 4B ) and measured corresponding TLR7 and 9 activities ( Figure 4C) . Notably, TLR activities increased with increasing amounts of UNC93B1, suggesting that UNC93B1 boosts TLR responses in a dose-dependent manner. The maximal TLR7 response was lower in the presence of ER-retained UNC93B1 than in the presence of WT UNC93B1. However, the minimal effective dose to increase TLR responses appeared very similar between UNC93B1 WT and UNC93B1 WT-ER. These results strongly argue against a model in which minute endosomal amounts of leaky UNC93B1 WT-ER could almost fully restore TLR responses and suggest that UNC93B1 serves critical dose-dependent functions independent of its endosomal trafficking activity.
ER-Retained UNC93B1 Enables TLR Trafficking to Endosomes
Endosomal TLR activities are known to depend on endosomal acidification (Blasius and Beutler, 2010) . Experimental ER retention of UNC93B1, however, might result in an alternative signaling mode. To gain insights into the signaling requirements, we therefore treated the cells with the H + -ATPase inhibitor bafilomycin A1 and examined TLR activity upon cellular activation with TLR7-stimulatory RNA, R848, CpG1826, and LPS. In accordance with previous reports, activity of TLRs 7 and 9, but not 4, was blocked by bafilomycin A1. Notably, this was true independently of UNC93B1 WT or UNC93B1 WT-ER expression (Figure 5A) , suggesting that in both cases TLR activation occurred in acidified compartments. This led us to analyze the subcellular localization of TLR7 in the presence of the different UNC93B1 versions. In the absence of UNC93B1, TLR7 was completely Endo H sensitive, corroborating the inability of the receptor to pass through the Golgi apparatus ( Figure 5B ). In iMOs expressing UNC93B1 WT and UNC93B1 WT-ER, a cleaved version of TLR7 appeared, and this cleaved version of TLR7 carried Endo H-resistant oligosaccharides. Endo H-resistant full-length TLR7 was hardly detectable in macrophages expressing WT UNC93B1, but a partly Endo H-resistant form accumulated in macrophages expressing the ER-retained version of UNC93B1. Of note, these TLR7 versions that carried Endo H-resistant oligosaccharides appeared in iMOs expressing the ER-retained and completely Endo H-sensitive version of UNC93B1 ( Figure 1D ). Hence, functional UNC93B1 prior to the Golgi is sufficient for TLR7 to readily traverse the Golgi apparatus on its own.
Given that ER-retained UNC93B1 was sufficient to support trafficking of TLR7 through the Golgi apparatus but resulted in a stronger accumulation of partly Endo H-resistant full-length TLR7 than WT UNC93B1, we next analyzed the ability of TLR7 to reach RNA ligand-containing compartments. To this end, we incubated iMOs expressing UNC93B1-mCitrine WT, H412R, or WT-ER with fluorescent RNA-streptavidin complexes and visualized endogenous TLR7 by immunofluorescence. TLR7 localized to RNA-containing endosomes to similar (A) HEK cells stably expressing human TLRs 7 or 9 and human UNC93B1-mCitrine WT or WT-ER were stimulated for 14 hr with 0.5 mM R848, 0.5 mM CpG2006, or 10 ng/mL TNF and analyzed for IL-8 secretion. Data are combined from three independent experiments (mean + SEM).
(B and C) HEK cells stably expressing human TLRs 7 or 9 were transiently transfected with decreasing concentrations of human UNC93B1-mCitrine WT or WT-ER as shown in (B), stimulated with 1 mM R848 or 0.5 mM CpG2006, and analyzed for IL-8 secretion as shown in (C). Data are combined from three independent experiments (mean + SEM).
extents in iMOs expressing UNC93B1-mCitrine WT and those expressing UNC93B1-mCitrine WT-ER ( Figure 5C ). The fact that TLR7, but not UNC93B1 WT-ER ( Figure 2D ), localized to RNA-containing compartments suggests that the experimental retention of UNC93B1 to the ER causes the trafficking pathways of TLR and UNC93B1 to separate at some point. Indeed, overall colocalization of TLR7 and UNC93B1 WT-ER were significantly reduced in comparison to the colocalization of TLR7 and WT UNC93B1 ( Figure 5D ). We also compared WT UNC93B1-mCitrine expressing Unc93b1 À/À iMOs with WT iMOs expressing endogenous UNC93B1 and found that UNC93B1 colocalized with TLR7 to similar extents in both cell lines ( Figure S3 ). Notably, immunofluorescence staining furthermore revealed that endogenous TLR7 was hardly detectable in iMOs expressing the non-functional UNC93B1 H412R mutant ( Figures 5C and  5D , middle panel). Together, our data indicate that the presence of functional UNC93B1 prior to the Golgi apparatus is sufficient to enable TLR trafficking through the Golgi apparatus to endosomal compartments in which TLRs are proteolytically processed and TLR ligands are present.
UNC93B1 Is Essential for Stabilizing TLRs
The absence of endogenous TLR7 in UNC93B1 H412R-expressing cells ( Figures 5C and 5D ) was surprising. To follow up on this finding, we analyzed protein expression of endogenous TLR7 in Unc93b1 À/À iMOs and UNC93B1 À/À iMOs expressing UNC93B1-mCitrine WT, H412R, and WT-ER by flow cytometry. Endogenous TLR7 was undetectable in the absence of UNC93B1 ( Figure 6A , lower panel). Reconstitution of Unc93b1 À/À iMOs with UNC93B1 H412R resulted in only a minor increase of TLR7 expression, whereas reconstitution with UNC93B1 WT or WT-ER rescued the defect and normalized TLR7 expression ( Figure 6A , lower panel). Furthermore, we used immunoblotting to quantify amounts of full-length versus cleaved TLR7 in iMOs stably expressing the different versions of UNC93B1. In accordance with previous findings (Lee et al., 2013) , cleaved TLR7 was not detectable in the absence of UNC93B1 or the presence of the non-functional H412R mutant UNC93B1 ( Figure 6B antibody. The graph represents the overall correlation between UNC93B1 and TLR7; each data point represents one independent experiment. Shown are data from three independent experiments (mean ± SEM). A Shapiro-Wilk normality test showed normal a distribution of data. A paired t test revealed significance (p = 0.019). Please also see Figure S3 for endogenous UNC93B1 and TLR7. Scale bars: 5 mm.
TLR7 form was more abundant in cells expressing UNC93B1 WT-ER. Notably, in cells expressing either UNC93B1 WT or UNC93B1 WT-ER, total amounts of TLR7 were strongly increased compared to TLR7 amounts in Unc93b1 À/À iMOs and Unc93b1 À/À iMOs reconstituted with the non-functional UNC93B1 H412R mutant ( Figure 6B , quantification). To assess whether this was due to an increased TLR half-life, we performed pulse-chase experiments. Unc93b1 À/À iMOs and Unc93b1 À/À iMOs reconstituted with WT UNC93B1 were metabolically labeled for 30 min with ]cysteine, and after chase periods of 0, 2, 4, 8, and 12 hr in label-free medium, endogenous TLR7 was immunoprecipitated from cell lysates ( Figure 6C ). The 0 hr time point shows comparable amounts of the full-length (immature) TLR7 in the presence or absence of UNC93B1, suggesting that similar amounts of TLR7 were synthesized within the metabolic labeling pulse. In macrophages expressing WT UNC93B1, the signal for full-length TLR7 started to decrease after 4 hr of chase, whereas cleaved (mature) TLR7 started to appear, accumulated after 8 hr, and was still well detectable after 12 hr of chase. In the absence of UNC93B1, full-length TLR7 disappeared with slightly faster kinetics. Furthermore, and as reported previously (Lee et al., 2013) , the cleaved form of TLR7 is not produced in the absence of UNC93B1, resulting in the complete lack of metabolically labeled TLR7 after 8 hr of chase.
We were also interested in whether the stabilizing effect of UNC93B1 was specific to TLR7 or a general function of UNC93B1 for potentially all UNC93B1-dependent TLRs. (D) Quantitative proteomics of Unc93b1 À/À iMO and Unc93b1 À/À iMO reconstituted with UNC93B1 WT. Shown are log2 LFQ endogenous abundances of the UNC93B1-independent TLRs 2 and 4 and the UNC93B1-dependent TLRs 3, 7, 9, and 13. In Unc93b1 À/À iMOs, UNC93B1 and TLR3 were not detectable.
Experiment was performed in triplicates, and significant differences are indicated with * (pairwise welch t test statistics, FDR = 0.05 and S0 = 1).
9, and 13 increased upon reconstitution with UNC93B1 (Figure 6D) , suggesting that the stabilizing function of UNC93B1 might be common to all UNC93B1-dependent TLRs. Figure 7B, upper panel) . Antibody specificities and the gating strategy for identifying these immune cell subsets are shown in Figure S4 . Importantly, antibodies of both TLR3 and TLR7 were shown to detect full-length (immature) and processed (mature) TLR forms Murakami et al., 2014) . In accordance with our findings in iMOs, TLRs 3 and 7 were hardly detectable in splenic cells from Unc93b1 À/À ( Figures 7A and 7B , middle panels) and Unc93b1 3d/3d mice ( Figures 7A and 7B , lower panels). Thus, UNC93B1 is crucial for maintaining expression of endogenous TLRs that functionally depend on UNC93B1, and the amounts of these TLRs are severely reduced in Unc93b1 À/À and Unc93b1 3d/3d mice. In light of these data, functional studies of endosomal TLRs in cells from Unc93b1 3d/3d mice cannot be interpreted as TLR trafficking defects, given that cells are quasideficient in endosomal TLRs.
DISCUSSION
The polytopic membrane protein UNC93B1 has gained researchers' attention for two reasons. First, UNC93B1 is essential for the host defense against HSV-1. UNC93B1-deficient patients are prone to developing HSV-1 encephalitis (Casrouge et al., 2006) , which most likely results from impaired TLR3 signaling in neurons and oligodendrocytes (Lafaille et al., 2012) . Second, UNC93B1 has been shown to act as a key regulator of NA-sensing TLRs (Fukui et al., 2011; Fukui et al., 2009) . According to the current understanding, UNC93B1 serves as a trafficking chaperone crucial for binding and guiding NA-sensing TLRs to endosomal compartments, where they encounter their respective ligands and initiate signaling (Brinkmann et al., 2007; Kim et al., 2008; Lee et al., 2013; Tabeta et al., 2006) . Recently, however, UNC93B1 has also been proposed to be essential for the function of TLR5, a receptor known to signal from the cell surface (Huh et al., 2014) . Given the different subcellular signaling compartments of the various UNC93B1-dependent TLRs, the current model, in which UNC93B1 is the determining factor that dictates TLR trafficking, implies that UNC93B1 can selectively transport its client TLRs to distinct locations. Cell-type-and stimulationspecific factors were speculated to influence the trafficking route of UNC93B1-TLR complexes (Huh et al., 2014) . However, the exact molecular mechanisms by which UNC93B1 enters and mediates differential trafficking pathways remains to be determined. The generation of an ER-retained version of UNC93B1 that is still capable of binding TLRs led us to the unexpected discovery that NA-sensing TLR activities were largely intact in the absence of endosomal UNC93B1. Notably, this was true for all investigated UNC93B1-dependent TLRs, including TLRs 7, 9, and 13, and could be observed in different cell types of mouse and human origin. Hence, our findings suggest that UNC93B1 regulates TLR maturation at an early step, presumably in the ER or on the route from the ER to the Golgi apparatus, a step that is most likely shared among all UNC93B1-dependent TLRs.
In addition, UNC93B1 trafficking might be required for the access of TLRs to specific signaling compartments, such as the IRF7-signaling compartment, which has been shown to be important for the secretion of type I IFNs (Sasai et al., 2010) . Indeed, UNC93B1 can itself traffic into post-Golgi , and Unc93b1 3d/3d mice were isolated and stained for different immune cell subsets, namely macrophages, pDCs, and CD4 + and CD8 + cDCs. Upon permeabilization, cells were stained with (A) biotinyated anti-TLR3 antibody (clone PAT3) (Murakami et al., 2014) followed by fluorescently labeled streptavidin (SA) or (B) biotinylated anti-TLR7 antibody (clone A94B10) followed by fluorescently labeled SA and analyzed by flow cytometry. Dotted histograms represent negative controls stained with fluorescently labeled SA alone. Data are representative of two independent experiments. Please see Figure S4 for gating strategies.
compartments and partially overlaps with UNC93B1-dependent TLRs in these compartments. Furthermore, TLR cleavage was reduced, and the EndoH-resistant full-length form of TLR7 accumulated upon retention of UNC93B1 to the ER, suggesting that retention of UNC93B1 did affect TLR trafficking. Nevertheless, TLR7 reached RNA-containing endosomal compartments as efficiently as in the presence of UNC93B1 WT. One drawback of our study is that ER-retained UNC93B1 could potentially leak into endosomal compartments in amounts that are below the detection limit of the applied biochemical and imaging-based assays. Leakage of UNC93B1 H412R would be functionally irrelevant because of its inability to interact with TLRs. However, UNC93B1 WT-ER is able to interact with TLRs, and even a few molecules might be functionally important. To explore this possibility, we tightly titrated the expression of UNC93B1 and assessed TLR function. Importantly, TLR activities increased as amounts of UNC93B1 increased, and effective doses of UNC93B1 were similar for UNC93B1 WT and WT-ER. These experiments suggest that UNC93B1 exerts a dose-dependent function that is preserved for both UNC93B1 WT and WT-ER.
Furthermore, it is worth noting that the trafficking of UNC93B1 and its client TLRs are separable events: TLR7 readily gained Endo H resistance indicative of its trafficking through the Golgi apparatus, whereas no Endo H-resistant forms of UNC93B1 WT-ER were detectable. Colocalization studies between UNC93B1 and TLR7 further confirmed that ER retention of UNC93B1 resulted in the subcellular segregation of UNC93B1 and its client receptors. Our approach highlights the importance of TLR-specific regulatory mechanisms that operate independently of those controlling UNC93B1 trafficking. Conceptually, the individual TLR-specific regulation of post-Golgi trafficking pathways might be beneficial for fine-tuned and contextadjusted TLR responses.
One major drawback in the analysis of NA-sensing TLR function in recent years has been the lack of sensitive antibodies against these TLRs. Consequently, previous studies analyzed overexpressed tagged versions of these TLRs or relied on metabolic labeling of endogenous TLRs, which enables their detection by immunoprecipitation and radiography. Heterologous expression of UNC93B1 and TLRs in HEK293 cells suggested that the presence of UNC93B1 prolongs the half-lives of TLRs 3 and 9 (Pohar et al., 2013; Qi et al., 2012) . On the other hand, WT and Unc93b1 3d/3d mutant mice were found to express equal amounts of metabolically labeled endogenous TLR7 (Brinkmann et al., 2007) . Notably, only the newly synthesized immature (fulllength) but not the mature (cleaved) pool of TLR7 was detected at the time. Thus, these results are consistent with our present finding that the initial biosynthesis of TLR7 is not impaired in the absence of UNC93B1. However, the question of whether the total amounts of endogenous UNC93B1-dependent TLRs are affected by the absence of UNC93B1 remained open.
The generation of antibodies suitable for the detection of endogenously expressed TLRs 3 (Murakami et al., 2014) and 7 enabled us to analyze the role of UNC93B1 for the expression and stability of these TLRs in their endogenous context and to answer this essential question. We discovered that UNC93B1 was crucial for maintaining expression of endogenous TLRs 3 and 7 in various types of primary immune cells. Total expression proteomes revealed that the same was true for endogenous TLR13, and to a slightly lesser extent TLR9, but not TLRs 2 and 4, which are known to function independently of UNC93B1.
The severely reduced expression of endogenous UNC93B1-dependent TLRs in the presence of the H412R mutant UNC93B1 compared to WT UNC93B1 has implications for previous (Brinkmann et al., 2007) as well as current interaction proteomics analyses. For example, the fact that UNC93B1-dependent TLR proteins were less abundant in UNC93B1 H412R immunoprecipitates could simply reflect the reduced total amounts of UNC93B1-dependent TLRs within these cells rather than the TLR binding defect of UNC93B1 H412R. Importantly, however, the failure of UNC93B1 H412R to interact with NA-sensing TLRs has been confirmed in HEK293 cells heterologously expressing both UNC93B1 and TLRs (Brinkmann et al., 2007) .
Previous studies have proposed that competition between TLRs 7 and 9 for UNC93B1-mediated trafficking is vital for keeping NA-sensing TLRs in check and preventing uncontrolled inflammation (Fukui et al., 2011; Fukui et al., 2009) . Our data propose that regulating the expression of UNC93B1 might be a key mechanism for modulating UNC93B1-dependent TLR function. In a clinical context, elevated UNC93B1 expression might stabilize NA-sensing TLRs and render them hyperactive. Notably, both type I IFN (Panchanathan et al., 2013; Pohar et al., 2013) and estrogen (Panchanathan et al., 2013 ) regulate UNC93B1 expression, and UNC93B1 is upregulated in female lupus-prone B6.Nba2 mice (Panchanathan et al., 2013) as well as in B cells of patients with active systemic lupus erythematosus (Nakano et al., 2010) . Hence, dysregulation on the level of UNC93B1 might contribute to autoimmunity by enhancing the expression and overall reactivity of UNC93B1-dependent TLRs.
Given the fundamental function of UNC93B1 in maintaining TLR protein expression, it furthermore appears likely that the major defect in UNC93B1-deficient patients is the instability of TLR proteins in the absence of UNC93B1. Whether UNC93B1 is involved in the folding process of TLRs or important for the ER export event itself is currently unknown. Immature glycoproteins undergo constant glycosylation and deglycosylation cycles, allowing the binding of chaperones such as calnexin and calreticulin (Helenius and Aebi, 2004) . Glucosidase II, which was enriched in immunoprecipitates of UNC93B1 WT and WT-ER, but not of UNC93B1 H412R, is involved in the deglycosylation process necessary for releasing glycoproteins from ER chaperones and enables the ER exit of mature proteins (Helenius and Aebi, 2004) . These quality-control mechanisms ensure that only correctly folded proteins leave the ER and that misfolded proteins are targeted to the ER degradation pathway. Recently, so-called corrector agents (e.g., lumacaftor) greatly improved the treatment of cystic fibrosis in patients carrying the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) protein (Davies, 2015) . These small-molecule compounds stabilize misfolded CFTRs and thereby enable the trafficking of this ion channel to its site of action (the cell membrane) and restore function (Davies, 2015) . It is tempting to speculate that similar approaches might be successful in stabilizing TLRs in the absence of UNC93B1 and rescue NA-sensing TLR activity in UNC93B1-deficient patients.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Table S1 Experimental Models: Cell Lines
BMDMs (Unc93b1 (clone 185) (Casrouge et al., 2006) were reported previously, hTLR7HA (RRID:CVCL_Y410) and hTLR9HA HEK293 cell lines (RRID:CVCL_Y412) were purchased from Invivogen. Stable cell lines were generated by retroviral transduction and sorted for similar protein expression of UNC93B1 versions by flow cytometry as described in the detailed methods. M-CSF-derived bone marrow macrophages (BMDMs) and GM-CSF-derived bone marrow dendritic cells (BMDCs) were differentiated for 7 days in complete RPMI 1640 medium supplemented with 40 ng/ml M-CSF (R&D Systems) or 20 ng/ml GM-CSF (Immunotools), respectively, and retrovirally transduced with the different UNC93B1 versions on day 2 of the differentiation procedure. Immortalized mouse macrophages, BMDMs, BMDCs, hTLR7HA and hTLR9HA HEK293 cell lines were cultured in complete DMEM containing 10% (v/v) heat-inactivated and sterile filtered FBS and 1% (v/v) penicillin-streptomycin. THP-1 monocytes and EBV-immortalized B cells were cultured in complete RPMI containing 10% (v/v) heat-inactivated and sterile filtered FBS and 1% (v/v) penicillinstreptomycin. All cells were cultured at 37 C, 5% CO2. Cell lines were regularly tested for mycoplasma contamination and were found to be negative.
Mice WT C57BL/6J mice were purchased from Jackson Laboratory. Unc93b1 À/À mice were generated by Regeneron Pharmaceuticals, Inc. as part of the Knockout Mouse Project (KOMP ID VG10049) as described previously (Valenzuela et al., 2003) .
and Tlr7 À/À mice were bred under specific pathogen-free conditions at the University of Massachusetts Medical School in accordance with the regulations of the American Association for the Accreditation of Laboratory Animal Care. Experiments were performed with both male and female mice and results were not affected by the sex of the mice.
METHOD DETAILS
Immortalization of Unc93b1 -/-BMDMs
Femurs and tibiae of one Unc93b1 -/-mouse were removed, briefly sterilized using 70% ethanol and washed in 1x PBS. Bone marrow was harvested and passed through a 70 mm cell strainer, red blood cells were lysed. Cells were resuspended in complete DMEM medium supplemented with 40 ng/ml M-CSF, and divided into two T75 flasks. Cells were incubated for 3 days at 37 C, 5% CO2 until macrophages started to adhere to the flask. In order to immortalize the BMDMs, cell culture medium from one T75 flask was removed and replaced with 12 mL complete DMEM medium containing 50% (v/v) J2 recombinant retrovirus (Roberson and Walker, 1988) and 40 ng/ml M-CSF. Cells in the other T75 were left untouched as a control. After approximately 24 h, the virus-containing medium was removed and replaced with virus-free complete DMEM medium supplemented with 40 ng/ml M-CSF. Cells were allowed to recover for 24 hr before the viral transduction procedure was repeated. After removal of the virus-containing medium, cells were cultured in complete DMEM supplemented with 40 ng/ml M-CSF for another week. During this time, the non-immortalized control cells slowly started to die, while the immortalized cells started to form small colonies. Cells were passaged by using trypsin-EDTA with the control and the immortalized cells being treated exactly the same way. Approximately two weeks after the bone marrow harvest, the M-CSF concentration was started to be reduced in 1:2 dilution steps to 1 ng/ml M-CSF approximately three months after the immortalization. Up from then, the cells were grown in M-CSF-free complete DMEM. Frozen stocks of the Unc93b1 -/-immortalized macrophages were prepared from early passages by resuspending approximately 3 3 10 6 cells in 1 mL heat-inactivated FBS containing 10%
(v/v) DMSO. Immediately upon resuspension, cells were cooled down to À80 C at standardized cooling rates of À1 C /min in cell freezing containers. For long-term storage, frozen vials were transferred to À150 C. Immortalized Unc93b1 -/-macrophages were reconstituted with mouse UNC93B1-mCitrine versions using retroviral transduction as described in the next section.
Retroviral transduction and fluorescence activated cell sorting
For each viral supernatant to be produced, 3 3 10 6 HEK293T cells were plated in 10 mL complete DMEM in one 10 cm tissue culture dish. After 16 -24 h, HEK293T cells were transfected with retroviral constructs encoding the gene of interest (10 mg per dish) as well as the retroviral packaging plasmids gag-pol (10 mg per dish) and VSV-G (1 mg per dish) using GeneJuice transfection reagent (Novagen). Cells were incubated at 37 C, 5% CO2 for 5 -8 h, then 650 mL heat-inactivated FBS was carefully added to the cells and cells were incubated for another 24 h. After 24 h, the medium was exchanged with 10 mL of fresh complete DMEM. 48 hr upon transfection of the HEK293T cells, the viral supernatant was harvested and target cells (seeded to be 80% confluent on the day of transduction) were transduced. To this end, viral supernatant was collected using a 10 mL luer-lock syringe attached to a blunt 18G needle and filtered through a 0.45 mm filter unit into a 50 mL falcon. Medium on target cells was removed and undiluted viral supernatant was added immediately. Target cells were incubated with the viral supernatant for approximately 24 hr at 37 C, 5% CO2. The medium was changed to complete DMEM and transduced cells were passaged three times before frozen stocks were prepared. UNC93B1-mCitrine-positive cells were selected and normalized for comparable protein expression among the different verisons of UNC93B1 using fluorescence assisted cell sorting on a FACS Aria cell sorter.
Deglycosylation assay
Cells were lysed for 1 hr on ice in a buffer containing 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 5% glycerol, 1% digitonin and the complete EDTA-free protease inhibitor cocktail from Roche. Immunoprecipitations were performed from equal amounts of cleared protein lysate per sample (as measured by BCA) for at least 2 hr at 4 C using TrapGFP plates (ChromoTek) to precipitate UNC93B1-mCitrine and anti-mTLR7 A94B10 antibody coupled to protein G dynabeads to precipitate endogenous in a data dependent mode with a survey scan range of 300-1650 m/z and a resolution of 60,000 at m/z 200. 15 of the most abundant isotope patterns with a charge > 1 were isolated with a 1.4 Thomson (Th) isolation window and subjected to higher-energy collisional dissociation (HCD) fragmentation at a normalized collision energy of 27. Fragmentation spectra were acquired with a resolution of 15,000 at m/z 200. Dynamic exclusion of sequenced peptides was set to 30 s to reduce repeated peptide sequencing.
Confocal imaging experiments and analysis
Unc93b1
-/-macrophages expressing either mouse UNC93B1-mCitrine WT, H412R or WT-ER were incubated with complexes consisting of biotinylated TLR7 RNA and streptavidin-AlexaFluor647 (RNA-SA complexes, 0.5 mM final concentration) or fluorescent CpG 1826 (0.5 mM final concentration) as indicated for 45 min at 37 C. RNA-SA complexes were formed by incubating a 15-fold molar excess of RNA with tetrameric streptavidin-FluorAlexa647 for 15 min at room temperature. Upon incubation, cells were fixed with 2% PFA in PBS over night at 4 C. PFA was quenched by applying 50 mM NH4Cl in PBS for 10 min at room temperature. Specimens were washed twice with PBS and permeabilized with a solution containing 0.1% Saponin (w/v) and 0.5% BSA (w/v) for 5 minutes at room temperature. Endogenous mouse TLR7 was stained with anti-mTLR7 A94B10 antibody at a final concentration of 1 mg/ml diluted in PBS containing 0.1% Saponin (w/v) and 1.5% (w/v) BSA for 2 hr at room temperature. Specimens were washed three times with PBS and incubated with anti-mouse AlexaFluor647 antibody diluted 1:2000 in PBS containing 0.1% (w/v) Saponin and 1.5% (w/v) BSA for 30 min at room temperature. Cells were washed three times with PBS and imaged on a Leica SP5 SMD confocal microscope with a 63x/1.2 water immersion objective. For the imaging analysis in Figures 2C and 2D and 5C, Cell profiler (version 6c2d896) (Carpenter et al., 2006) was used to identify all RNA or DNA vesicles (as indicated) in 8 different fields of view for each experiment. RNA or DNA vesicles were defined as objects and colocalization of UNC93B1 or TLR7 with RNA or DNA objects was determined for each field of view. Each data point represents the mean colocalization for each experiment relative to UNC93B1 WT. For Figure 5D and Figure S3 , overall colocalization between UNC93B1 and TLR7 was determined by Cell profiler (version 6c2d896). Each data point represents the mean colocalization for each experiment.
Cell stimulation and cytokine measurements Cells were stimulated as indicated with TLR7-stimulatory RNA (5 0 -ACUG1CG1AG1CUU-X-UUCG1AG1CG1UCA-5 0 , G1 is 7-deazaguanosine, X is 1,2,3-propanetriol) from Idera Pharmaceuticals, R848 (InvivoGen), TLR13-stimulatory RNA (ORN Sa19, InvivoGen), LPS (InvivoGen), CpG1826 PTO (Metabion), CpG2006 (Metabion), heat-killed GBS (kind gift from Dr. G. Teti), human TNF (R&D Systems) or human IL-1b (R&D Systems). Transient transfections were performed using Lipofectamine 2000 transfection reagent (Thermo Fisher Scientific). Where indicated, cells were pre-incubated with Bafilomycin A1 (Biomol). Cytokines were measured using commercially available ELISA kits (R&D Systems and BD Biosciences).
Pulse chase experiment
Unc93b1
-/-iMOs and Unc93b1 -/-iMOs stably expressing WT UNC93B1 were starved in DMEM devoid of cysteine and methionine Saponin and incubated with streptavidin-APC diluted 1:10 000 in PBS containing 0.5% (w/v) BSA, 0.1% (w/v) Saponin for 30 min at room temperature. Cells were washed three times, measured on a LSRII flow cytometer, and analyzed using the FlowJo software. The monoclonal anti-mTLR7 A94B10 and anti-mTLR3 PAT3 (Murakami et al., 2014) antibodies used for flow cytometry, IP and IF experiments were described previously and detect both the cleaved and the full-length receptor (N-terminal epitopes) Murakami et al., 2014) .
Electron microscopy -morphology Unc93b1 -/-iMOs reconstituted with UNC93B1-mCitrine WT, H412R and WT-ER were fixed in 2.5% gluteraldehyde, 3% paraformaldehyde with 5% sucrose in 0.1M sodium cacodylate buffer (pH 7.4) for 1 hour, pelleted in a small eppendorf tube, washed three times with 0.1M sodium cacodylate buffer, and post fixed in 1% OsO 4 in veronal-acetate buffer for 1 hour. The pellet was stained overnight with 0.5% uranyl acetate in veronal-acetate buffer, dehydrated and embedded in Embed 812 resin. Sections were cut on a Leica Ultracut UCT microtome with a Diatome diamond knife at a thickness setting of 50 nm, stained with uranyl acetate, and lead citrate. The sections were examined using a FEI Tecnai Spirit at 80 KV.
Electron microscopy -cryo-EM
Unc93b1
-/-iMOs reconstituted with UNC93B1-mCitrine WT, H412R and WT-ER were fixed mildly using PLP (paraformaldehyde/ lysine/sodium periodate) fixative for 4 hrs. Cells were pelleted and trimmed into small (< 1 mmsq) blocks. Blocks were infused with a cryo-protectant for at least one hour (PVP/sucrose), mounted onto cryo-pins, and snap frozen in liquid nitrogen. Ultrathin sections were cut at À110 C with a Leica UC7 equipped with a FC7 cryo-stage using a glass knife, and immunolabeled for GFP (Invitrogen Catalognr. A11122), stained and embedded using the Tokuyasu technique. The material was examined using a FEI Tecnai Spirit bioTWIN.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the definition of center, dispersion and precision measures (mean ± SEM) and statistical significance are reported in the Figures and Figure Legends . Data is judged to be statistically significant when p < 0.05 by two-tailed Student's t test (if normally distributed); nonparametric data are analyzed using a Mann-Whitney U-test. To compare several groups, a one-way ANOVA is used. In figures, asterisks denote statistical significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001, ****, p < 0.0001). Statistical analysis was performed in GraphPad PRISM 7 (Graph Pad Software Inc.) for imaging quantifications. For proteomics data, statistical methods are described in detail in the MS data analysis section and were performed with R (Team, R Development Core, 2008).
DATA AND SOFTWARE AVAILABILITY
The quantitative proteomics dataset of UNC93B1 WT, H412R, and WT-ER immunoprecipitates (related to Figures 2A and 2B ) is available in Table S1 .
